Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$116.80
+0.09%
Mkt Cap $9.12B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (72 analysts)
$138.07
Range $97.00 – $180.00
Implied Upside
+18.2%
Consensus $138.07 vs current $116.80
NASDAQ·Healthcare·Biotechnology
$116.80
+0.09%
Mkt Cap $9.12B
Buy
15
Hold
0
Sell
0
Price Target (72 analysts)
$138.07
Range $97.00 – $180.00
+18.2%
Consensus $138.07 vs current $116.80